The Memory Disorders Program is conducting the following ongoing clinical trials. These trials are underway and are no longer recruiting participants.
|Ongoing||Home-Based Assessment for Alzheimer's Disease Prevention (HBA)||Trial||National Institute on Aging/Alzheimer's Disease Cooperative Trial|
|Ongoing||Study Evaluating ACC-001 in Mild to Moderate Alzheimer's Disease Subjects||Trial||Wyeth|
|Ongoing||A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer's Disease||Trial||Baxter/ADCS|
|Ongoing||Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Mild to Moderate Alzheimer's Disease (ACCTION)||Trial||JANSSEN Alzheimer Immunotherapy|
|Ongoing||Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Early Alzheimer's Disease||Trial||Pfizer|
|Ongoing||Randomized, Controlled Study Evaluating CERE-110 in Subjects With Mild to Moderate Alzheimer's Disease||Trial||Ceregene/ADCS|
|Ongoing||Phase II Study to Evaluate the Impact on Biomarkers of Resveratrol Treatment in Patients With Mild to Moderate Alzheimer"s Disease||Trial||ADCS|
A list of research studies that are Recruiting is also available.